A detailed history of Blair William & CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Blair William & CO holds 60,266 shares of FOLD stock, worth $577,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,266
Previous 47,254 27.54%
Holding current value
$577,348
Previous $468,000 37.39%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$9.55 - $12.09 $124,264 - $157,315
13,012 Added 27.54%
60,266 $643,000
Q2 2024

Aug 12, 2024

BUY
$9.04 - $11.75 $56,382 - $73,284
6,237 Added 15.21%
47,254 $468,000
Q1 2024

May 09, 2024

BUY
$11.43 - $14.24 $1,165 - $1,452
102 Added 0.25%
41,017 $483,000
Q4 2023

Feb 12, 2024

BUY
$9.97 - $14.52 $54,446 - $79,293
5,461 Added 15.4%
40,915 $580,000
Q3 2023

Nov 09, 2023

BUY
$11.78 - $13.86 $417,648 - $491,392
35,454 New
35,454 $431,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.